• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Antinuclear antibodies in COVID 19.

作者信息

Muratori Paolo, Lenzi Marco, Muratori Luigi, Granito Alessandro

机构信息

Division of Internal Medicine, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.

Department for the Science of the Quality of Life (QUVI), Alma Mater Studiorum, University of Bologna, Bologna, Italy.

出版信息

Clin Transl Sci. 2021 Sep;14(5):1627-1628. doi: 10.1111/cts.13026. Epub 2021 May 1.

DOI:10.1111/cts.13026
PMID:33932091
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8239781/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d60/8504848/24a424f2f166/CTS-14-1627-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d60/8504848/24a424f2f166/CTS-14-1627-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d60/8504848/24a424f2f166/CTS-14-1627-g001.jpg

相似文献

1
Antinuclear antibodies in COVID 19.新型冠状病毒肺炎中的抗核抗体
Clin Transl Sci. 2021 Sep;14(5):1627-1628. doi: 10.1111/cts.13026. Epub 2021 May 1.
2
Is COVID-19 severity unrelated to antinuclear antibodies?COVID-19 严重程度与抗核抗体无关？
Transpl Immunol. 2023 Jun;78:101791. doi: 10.1016/j.trim.2023.101791. Epub 2023 Jan 20.
3
Role of antinuclear antibodies in COVID-19 patients.抗核抗体在新冠病毒肺炎患者中的作用。
J Immunol Methods. 2022 Mar;502:113215. doi: 10.1016/j.jim.2022.113215. Epub 2022 Jan 6.
4
Lack of Antinuclear Antibodies in Convalescent Coronavirus Disease 2019 Patients With Persistent Symptoms.2019冠状病毒病康复期仍有持续症状患者缺乏抗核抗体
Clin Infect Dis. 2022 Jun 10;74(11):2083-2084. doi: 10.1093/cid/ciab890.
5
High prevalence of antinuclear antibodies and lupus anticoagulant in patients hospitalized for SARS-CoV2 pneumonia.因新型冠状病毒肺炎住院患者中抗核抗体和狼疮抗凝物的高流行率。
Clin Rheumatol. 2020 Jul;39(7):2095-2097. doi: 10.1007/s10067-020-05180-7. Epub 2020 May 27.
6
Autoantibodies in COVID-19 correlate with antiviral humoral responses and distinct immune signatures.COVID-19 中的自身抗体与抗病毒体液反应和独特的免疫特征相关。
Allergy. 2022 Aug;77(8):2415-2430. doi: 10.1111/all.15302. Epub 2022 Apr 8.
7
Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: Causality or casualty?2019冠状病毒病（COVID-19）疫苗接种后发生的自身免疫性肝炎：是因果关系还是偶然事件？
J Hepatol. 2021 Jul;75(1):222-224. doi: 10.1016/j.jhep.2021.04.003. Epub 2021 Apr 20.
8
Positive Anti-SSA/Ro Antibody in a Woman with SARS-CoV-2 Infection Using Immunophenotyping: A Case Report.感染 SARS-CoV-2 后应用免疫表型检测出抗 SSA/Ro 抗体阳性：病例报告。
Medicina (Kaunas). 2020 Oct 5;56(10):521. doi: 10.3390/medicina56100521.
9
Anti-heart antibodies levels and their correlation with clinical symptoms and outcomes in patients with confirmed or suspected diagnosis COVID-19.抗心脏抗体水平及其与确诊或疑似 COVID-19 患者的临床症状和结局的相关性。
Eur J Immunol. 2021 Apr;51(4):893-902. doi: 10.1002/eji.202048930. Epub 2021 Jan 27.
10
Natural IgG against S-Protein and RBD of SARS-CoV-2 Do Not Bind and Hydrolyze DNA and Are Not Autoimmune.天然 IgG 针对 SARS-CoV-2 的 S 蛋白和 RBD 不结合和水解 DNA，也不是自身免疫的。
Int J Mol Sci. 2022 Nov 8;23(22):13681. doi: 10.3390/ijms232213681.

引用本文的文献

1
COVID-19 Induced Cholangiopathy: A Case Report.新型冠状病毒肺炎诱发的胆管病：一例报告
Case Rep Gastroenterol. 2025 Jul 16;19(1):519-526. doi: 10.1159/000546723. eCollection 2025 Jan-Dec.
2
SARS-CoV-2 Variant-Specific Antibodies in Vaccinated Inflammatory Bowel Disease Patients.接种疫苗的炎症性肠病患者体内的新冠病毒变异株特异性抗体
Vaccines (Basel). 2025 May 30;13(6):595. doi: 10.3390/vaccines13060595.
3
From infection to autoimmunity: can COVID-19 spark new auto-immune conditions?从感染到自身免疫：新冠病毒会引发新的自身免疫疾病吗？

本文引用的文献

1
Autoantibodies in moderate and critical cases of COVID-19.新冠病毒肺炎中重度和危重症病例中的自身抗体。
Clin Transl Sci. 2021 Sep;14(5):1625-1626. doi: 10.1111/cts.13036. Epub 2021 May 2.
2
Autoantibodies in COVID-19: frequency and function.新冠病毒感染中的自身抗体：频率与功能
Autoimmun Rev. 2021 Mar;20(3):102754. doi: 10.1016/j.autrev.2021.102754. Epub 2021 Jan 18.
3
Prevalence of autoantibody responses in acute coronavirus disease 2019 (COVID-19).2019年新型冠状病毒病（COVID-19）中自身抗体反应的患病率。
Respir Med Case Rep. 2025 Apr 26;55:102216. doi: 10.1016/j.rmcr.2025.102216. eCollection 2025.
4
Clinical Course and Outcome of COVID-19 in Children With Biliary Atresia: A Retrospective Study.胆道闭锁患儿新冠病毒病的临床病程及转归：一项回顾性研究
Health Sci Rep. 2025 Feb 10;8(2):e70462. doi: 10.1002/hsr2.70462. eCollection 2025 Feb.
5
The Impact of Comorbidity and Age on the Risk of Hospitalization and Mortality in Patients with Previous COVID-19 Infection-Based on Nationwide Data.基于全国数据探讨合并症和年龄对既往感染新型冠状病毒肺炎患者住院风险和死亡风险的影响
J Clin Med. 2024 Oct 30;13(21):6522. doi: 10.3390/jcm13216522.
6
Clonal landscape of autoantibody-secreting plasmablasts in COVID-19 patients.COVID-19 患者中分泌自身抗体的浆母细胞的克隆景观。
Life Sci Alliance. 2024 Sep 17;7(12). doi: 10.26508/lsa.202402774. Print 2024 Dec.
7
Histopathological impact of SARS-CoV-2 on the liver: Cellular damage and long-term complications.SARS-CoV-2 对肝脏的组织病理学影响：细胞损伤和长期并发症。
World J Gastroenterol. 2024 Jun 14;30(22):2866-2880. doi: 10.3748/wjg.v30.i22.2866.
8
The Onset of Antinuclear Antibodies (ANAs) as a Potential Risk Factor for Mortality and Morbidity in COVID-19 Patients: A Single-Center Retrospective Study.抗核抗体（ANA）的出现作为COVID-19患者死亡和发病的潜在危险因素：一项单中心回顾性研究。
Biomedicines. 2024 Jun 13;12(6):1306. doi: 10.3390/biomedicines12061306.
9
Serum SARS-CoV-2 antibodies in HIV-1-infected patients after inactivated vaccination and SARS-CoV-2 infection.HIV-1感染患者在接种灭活疫苗和感染SARS-CoV-2后的血清SARS-CoV-2抗体
Heliyon. 2024 May 23;10(11):e31731. doi: 10.1016/j.heliyon.2024.e31731. eCollection 2024 Jun 15.
10
Risk of flare or relapse in patients with immune-mediated diseases following SARS-CoV-2 vaccination: a systematic review and meta-analysis.接种 SARS-CoV-2 疫苗后免疫介导性疾病患者出现 flares 或复发的风险：一项系统评价和荟萃分析。
Eur J Med Res. 2024 Jan 17;29(1):55. doi: 10.1186/s40001-024-01639-4.
J Transl Autoimmun. 2020;3:100073. doi: 10.1016/j.jtauto.2020.100073. Epub 2020 Nov 27.
4
COVID-19 and Immunological Dysregulation: Can Autoantibodies be Useful?COVID-19 与免疫失调：自身抗体是否有用？
Clin Transl Sci. 2021 Mar;14(2):502-508. doi: 10.1111/cts.12908. Epub 2021 Jan 20.
5
Antibodies to SS-A/Ro-52kD and centromere in autoimmune liver disease: a clue to diagnosis and prognosis of primary biliary cirrhosis.自身免疫性肝病中抗SS - A/Ro - 52kD抗体和着丝粒抗体：原发性胆汁性肝硬化诊断和预后的线索
Aliment Pharmacol Ther. 2007 Sep 15;26(6):831-8. doi: 10.1111/j.1365-2036.2007.03433.x.